Qtron Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,982
Closed -$221K 425
2024
Q4
$221K Sell
13,982
-11,113
-44% -$167K 0.03% 392
2024
Q3
$399K Hold
25,095
0.05% 354
2024
Q2
$382K Sell
25,095
-48,310
-66% -$692K 0.06% 359
2024
Q1
$1.08M Hold
73,405
0.15% 173
2023
Q4
$1.02M Buy
73,405
+18,450
+34% +$247K 0.17% 151
2023
Q3
$735K Sell
54,955
-89,900
-62% -$1.22M 0.14% 208
2023
Q2
$1.83M Buy
144,855
+22,050
+18% +$257K 0.35% 63
2023
Q1
$1.4M Buy
122,805
+65,600
+115% +$708K 0.29% 82
2022
Q4
$592K Buy
+57,205
New +$617K 0.12% 231
2021
Q1
Sell
-107,120
Closed -$1.53M 370
2020
Q4
$1.53M Sell
107,120
-17,950
-14% -$242K 0.41% 49
2020
Q3
$1.74M Sell
125,070
-74,350
-37% -$886K 0.61% 28
2020
Q2
$2.11M Buy
199,420
+45,095
+29% +$459K 0.85% 19
2020
Q1
$1.25M Hold
154,325
0.75% 21
2019
Q4
$1.25M Hold
154,325
0.72% 29
2019
Q3
$1.17M Hold
154,325
0.71% 29
2019
Q2
$1.16M Buy
154,325
+10,685
+7% +$84K 0.72% 25
2019
Q1
$1.16M Buy
143,640
+104,640
+268% +$795K 1.06% 14
2018
Q4
$294K Buy
+39,000
New +$274K 0.23% 99

Other funds holding RDY

Qtron Investments's RDY Position: Q1 2025 in Review

Qtron Investments sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 13,982 shares — an estimated $221K sold.

Qtron Investments first reported a position in RDY in Q4 2018 and held it in 18 quarters. The position peaked at $2.11M in Q2 2020. 244 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Qtron Investments reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Qtron Investments sold 13,982 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $221K.
  • Qtron Investments first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 18 quarters.
  • Qtron Investments's Dr. Reddy's Laboratories position peaked at $2.11M in Q2 2020.
  • 244 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Qtron Investments's 13F filing for Q1 2025, filed 13 May 2025.